Allscripts Healthcare Solutions Stock Fundamentals
| AL21 Stock | 4.50 0.00 0.00% |
Allscripts Healthcare Solutions fundamentals help investors to digest information that contributes to Allscripts Healthcare's financial success or failures. It also enables traders to predict the movement of Allscripts Stock. The fundamental analysis module provides a way to measure Allscripts Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allscripts Healthcare stock.
Allscripts |
Allscripts Healthcare Solutions Company EBITDA Analysis
Allscripts Healthcare's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Allscripts Healthcare EBITDA | 351.13 M |
Most of Allscripts Healthcare's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allscripts Healthcare Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Allscripts Healthcare Solutions reported earnings before interest,tax, depreciation and amortization of 351.13 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.
Allscripts Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Allscripts Healthcare's current stock value. Our valuation model uses many indicators to compare Allscripts Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allscripts Healthcare competition to find correlations between indicators driving Allscripts Healthcare's intrinsic value. More Info.Allscripts Healthcare Solutions is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Allscripts Healthcare Solutions is about 986,009,450 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Allscripts Healthcare's earnings, one of the primary drivers of an investment's value.Allscripts EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allscripts Healthcare's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allscripts Healthcare could also be used in its relative valuation, which is a method of valuing Allscripts Healthcare by comparing valuation metrics of similar companies.Allscripts Healthcare is currently under evaluation in ebitda category among its peers.
Allscripts Fundamentals
| Current Valuation | 1.65 B | |||
| Price To Book | 1.67 X | |||
| Price To Sales | 1.57 X | |||
| Revenue | 1.5 B | |||
| EBITDA | 351.13 M | |||
| Net Income | 134.44 M | |||
| Total Debt | 350.06 M | |||
| Cash Flow From Operations | (75.43 M) | |||
| Price To Earnings To Growth | 2.37 X | |||
| Market Capitalization | 1.92 B | |||
| Total Asset | 2.43 B | |||
| Z Score | 3.0 | |||
| Net Asset | 2.43 B |
About Allscripts Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allscripts Healthcare Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allscripts Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allscripts Healthcare Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Allscripts Stock Analysis
When running Allscripts Healthcare's price analysis, check to measure Allscripts Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allscripts Healthcare is operating at the current time. Most of Allscripts Healthcare's value examination focuses on studying past and present price action to predict the probability of Allscripts Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allscripts Healthcare's price. Additionally, you may evaluate how the addition of Allscripts Healthcare to your portfolios can decrease your overall portfolio volatility.